Concise manual of hematology and oncology: with 474 tables
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Berlin [u.a.]
Springer
2008
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis Klappentext |
| Beschreibung: | XXI, 1002 S. Ill., graph. Darst. |
| ISBN: | 9783540732761 3540732764 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV023335129 | ||
| 003 | DE-604 | ||
| 005 | 20101126 | ||
| 007 | t | ||
| 008 | 080609s2008 gw ad|| |||| 00||| eng d | ||
| 015 | |a 07,N32,0653 |2 dnb | ||
| 016 | 7 | |a 984966005 |2 DE-101 | |
| 020 | |a 9783540732761 |c Gb. : ca. EUR 106.95 (freier Pr.), ca. sfr 174.00 (freier Pr.) |9 978-3-540-73276-1 | ||
| 020 | |a 3540732764 |c Gb. : ca. EUR 106.95 (freier Pr.), ca. sfr 174.00 (freier Pr.) |9 3-540-73276-4 | ||
| 024 | 3 | |a 9783540732761 | |
| 028 | 5 | 2 | |a 11531630 |
| 035 | |a (OCoLC)271648600 | ||
| 035 | |a (DE-599)DNB984966005 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BE | ||
| 049 | |a DE-355 |a DE-19 | ||
| 082 | 0 | |a 616.15 |2 22/ger | |
| 084 | |a XH 1508 |0 (DE-625)152870:12914 |2 rvk | ||
| 084 | |a YC 2308 |0 (DE-625)153200:12914 |2 rvk | ||
| 084 | |a 610 |2 sdnb | ||
| 245 | 1 | 0 | |a Concise manual of hematology and oncology |b with 474 tables |c ed. D. P. Berger ... |
| 264 | 1 | |a Berlin [u.a.] |b Springer |c 2008 | |
| 300 | |a XXI, 1002 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Hämatologie |0 (DE-588)4022796-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Hämatologie |0 (DE-588)4022796-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Berger, Dietmar Paul |e Sonstige |0 (DE-588)111674808 |4 oth | |
| 856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016519008&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016519008&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |3 Klappentext |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-016519008 | ||
Datensatz im Suchindex
| _version_ | 1804137685140373504 |
|---|---|
| adam_text | Contents
1
Principles of Medical Oncology
1.1
Epidemiology
..................................................... 1
1.2
Carcinogenesis, Molecular Tumor Biology
.......................... 3
1.3
Hematopoiesis and Development of Hematological
Neoplasia
........ 7
1.4
Prevention and Screening
.......................................... 10
1.5
Classification of Diseases and ICD System
.......................... 14
1.6
Tumor Classification and TNM System
............................. 17
1.7
Indications for Tumor Therapy
..................................... 19
1.8
Performance Status of Tumor Patients ( Performance Status Scales )
.. 21
1.9
Response Evaluation in Solid Tumors
............................... 22
1.10
Common
Toxicity
Criteria (NCI)
................................... 25
1.11
Assessing the Quality of Life of Tumor Patients
...................... 30
1.12
Evidence-based Medicine (EBM), Guidelines and Quality
Management
...................................................... 32
1.13
Electronic Media
.................................................. 35
2
Special Diagnostics
2.1
Cytogenetics and Fluorescence In Situ Hybridization (FISH)
......... 39
2.2
Molecular Diagnosis
............................................... 42
2.3
Gene Expression Analysis using Microarrays
........................ 45
2.4
Tumor Markers
.................................................... 47
2.5
CD Antigens and Immunocytological Diagnosis
..................... 51
2.6
HLA
System and MHC
............................................ 62
3
Pharmacology and Pharmacotherapy
3.1
Basic Principles of Chemotherapy
.................................. 65
3.2
Cytostatic Drugs
.................................................. 69
3.2.1
Characteristics of Clinically Used Cytostatic Drugs
.................. 71
3.2.2
Check List Cytostatic Treatment
.................................... 131
3.2.3
Drug Dosage Calculation Based on Body Surface Area (BSA)
........ 132
3.2.4
Dose Adjustment of Cytostatic Drugs
............................... 134
3.2.5
Chemotherapy During Pregnancy and Lactation
.................... 141
3.2.6
Selected Cytostatic Drug Incompatibilities
.......................... 143
3.2.7
Preparation and Stability of Cytostatics
............................. 146
3.3
Hormone Therapy
................................................. 153
3.3.1
Characterization of Hormone Treatments in Oncology
.............. 156
3.4
Cytokines
......................................................... 170
3.5
Monoclonal Antibodies
............................................ 178
3.6
Specific Protein Kinase Inhibitors ( Targeted Therapies )
............ 188
3.7
Drug Development and Clinical Studies
............................ 198
3.8
Pharmacogenetics and Pharmacogenomics
.......................... 201
4
Supportive Treatment
4.1
Antiemetic Prophylaxis and Therapy
................................ 204
4.2
Antibiotic Treatment and Neutropenic Fever
........................ 211
Contents
4.3
Growth Factors
.................................................... 218
4.4
Nutrition in Cancer Patients
....................................... 225
4.4.1
Malnutrition in Cancer Patients
.................................... 225
4.4.2
Parenteral Nutrition
............................................... 232
4.5
Pain Control
...................................................... 235
4.6
Fatigue
............................................................ 241
4.7
Bisphosphonates
.................................................. 243
4.8
Malignant Effusions
............................................... 249
4.8.1
Malignant
Pleural
Effusion
......................................... 250
4.8.2
Malignant Pericardial Effusion
..................................... 254
4.8.3
Malignant
Ascites
................................................. 257
4.9
Transfusion Therapy
............................................... 261
4.9.1
Cellular Blood Products
........................................... 261
4.9.2
Non-cellular Blood Products
....................................... 267
4.10
Human Sperm Cryopreservation
................................... 271
4.11
Cryopreservation of Human Pronuclear Oocytes
.................... 274
4.12
Sexual Dysfunction
................................................ 276
4.13
Physiotherapy and Sports Medicine
................................. 278
4.14
Principles of Oncology Nursing Care
............................... 281
4.15
Psycho-oncological Care
........................................... 286
4.16
Rehabilitation
..................................................... 289
5
Particular Treatment Procedures
5.1
Hematopoetic Stem Cell Technology (Harvesting, Culture, Purging)
.. 293
5.2
Autologous Hematopoetic Stem Cell Transplantation
................ 296
5.3
Allogeneic Hematopoetic Stem Cell Transplantation
................. 302
5.4
Granulocyte Transfusion
........................................... 309
5.5
Immunotherapy
................................................... 311
5.6
Gene Therapy
..................................................... 315
5.7
Inhibition of Angiogenesis
......................................... 319
5.8
Developmental Therapeutics
....................................... 322
6
Hematology
and Hemostasis
6.1
Aplastic Anemia
................................................... 327
6.2
Neutropenia and Agranulocytosis
.................................. 332
6.3
Thrombocytopenia
................................................ 336
6.3.1
Immune (Idiopathic) Thrombocytopenic
Purpura
(ITP, Werlhof
s
Disease)
........................................... 339
6.3.2
Heparin-induced Thrombocytopenia (HIT)
......................... 343
6.3.3
Thrombotic Microangiopathies (TTP-HUS)
......................... 345
6.4
Anemia
........................................................... 348
6.4.1
Hypochromic Anemia
............................................. 351
6.4.2
Megaloblastic Anemia
............................................. 355
6.4.3
Hemolytic Anemia
................................................ 359
6.4.4
Normochromic Anemia
............................................ 369
6.5
Coagulation Disorders
............................................. 371
6.5.1
Acquired Coagulation Disorders
................................... 376
6.5.2
Factor
VIII
Deficiency (Hemophilia A)
............................. 381
VIII
Contents
6.5.3
Factor
IX Deficiency (Hemophilia
В) ...............................
384
6.5.4
Von Willebranďs
Disease (VWD)
.................................. 386
6.5.5
Disseminated
Intravascular
Coagulation (DIC)
...................... 389
6.6
Thromboembolism and Thrombophilia
............................. 393
7
Hematological
Neoplasia
7.1
Acute
Leukémiás
.................................................. 400
7.1.1
Acute Lymphoblastic Leukemia (ALL)
.............................. 400
7.1.2
Acute Myeloid Leukemia (AML)
................................... 415
7.2
Myelodysplastic Syndrome (MDS)
.................................. 423
7.3
Myeloproliferative Disorders (MPD)
................................ 429
7.3.1
Chronic Myeloid Leukemia (CML)
................................. 431
7.3.2
Polycythemia
Vera
................................................. 439
7.3.3
Essential Thrombocythemia
........................................ 443
7.3.4
Chronic Idiopathic Myelofibrosis (CIMF)
........................... 447
7.4
Hodgkins Disease (Hodgkins Lymphoma)
.......................... 450
7.5 Non-Hodgkins Lymphomas (NHL) ................................. 458
7.5.1
High-grade Non-Hodgkins Lymphoma
............................. 463
7.5.2
Chronic Lymphocytic Leukemia (CLL)
............................. 470
7.5.3
Prolymphocytic Leukemia
(PLL)
................................... 477
7.5.4
Hairy Cell Leukemia (HCL)
........................................ 480
7.5.5
Follicular Lymphoma (FL)
......................................... 483
7.5.6
Mantle Cell Lymphoma (MCL)
..................................... 488
7.5.7
Primary Cutaneous
Т
-cell
Lymphoma (CTCL)
...................... 492
7.5.8
Primary Lymphoma of the Central Nervous System (CNS)
........... 498
7.5.9
Marginal Zone Lymphoma (MZL)
.................................. 502
7.5.10
Multiple Myeloma
................................................. 506
7.5.11
Immunocytoma
(Waldenström s Macroglobulinemia)
................ 515
7.6 Langerhans
Cell Histiocytosis (LCH)
............................... 518
7.7
Mastocytosis
...................................................... 522
8
Medical Oncology
8.1
Head and Neck Tumors
............................................ 528
8.2
Tumors of the Respiratory System
.................................. 535
8.2.1
Lung Cancer
...................................................... 535
8.2.2
Mesotheliomas
.................................................... 546
8.2.3
Mediastinal Tumors
............................................... 550
8.3
Gastrointestinal Tumors
........................................... 555
8.3.1
Esophageal Carcinoma
............................................. 555
8.3.2
Gastric Cancer
.................................................... 560
8.3.3
Cancer of the Small Intestine
....................................... 566
8.3.4
Colorectal Cancer
................................................. 570
8.3.5
Anal Carcinoma
................................................... 577
8.3.6
Pancreatic Carcinoma
............................................. 581
8.3.7
Hepatocellular Carcinoma (HCC)
.................................. 587
8.3.8
Tumors of the Gallbladder and Bile Duct
............................ 593
8.4
Tumors of the Female Reproductive System
......................... 597
8.4.1
Breast Cancer
..................................................... 597
IX
Contents
8.4.2
Malignant Ovarian Tumors
........................................ 611
8.4.3
Malignant Germ Cell Tumors in Women
............................ 619
8.4.4
Granulosa
Cell Tumors of the Ovary
................................ 623
8.4.5
Sertoli-Leydig Cell Tumors
......................................... 626
8.4.6
Malignant Trophoblastic Tumors
................................... 628
8.4.7
Cervical Cancer
................................................... 633
8.4.8
Endometrial Carcinoma
........................................... 640
8.4.9
Uterine Sarcoma
................................................... 646
8.4.10
Vaginal Cancer
.................................................... 649
8.4.11
Vulvar
Cancer
..................................................... 652
8.5
Tumors of the Male Reproductive System
........................... 656
8.5.1
Testicular Tumors
................................................. 656
8.5.2
Extragonadal Germ Cell Tumors
................................... 665
8.5.3
Prostate Cancer
................................................... 669
8.5.4
Penile Cancer
..................................................... 678
8.6
Tumors of the Urinary Tract
....................................... 682
8.6.1
Renal Cell Carcinoma
............................................. 682
8.6.2
Tumors of the Renal Pelvis, Ureter, and Bladder
..................... 688
8.7
Tumors of the Endocrine System
................................... 696
8.7.1
Thyroid Cancer
.................................................... 696
8.7.2
Neuroendocrine
Tumors (NET)
.................................... 702
8.7.3
Malignant Pheochromocytoma and MEN
........................... 709
8.7.4
Tumors of the Adrenal Cortex
...................................... 713
8.7.5
Pituitary Gland Tumors
............................................ 716
8.8
Malignant Tumors of the Skin
...................................... 719
8.8.1
Melanoma
........................................................ 719
8.8.2
Basal Cell Carcinoma
.............................................. 727
8.8.3
Squamous Cell Carcinoma
......................................... 729
8.8.4 Merkel
Cell Carcinoma
............................................ 732
8.9
Sarcomas
......................................................... 735
8.9.1
Soft Tissue Sarcoma
............................................... 735
8.9.2
Gastrointestinal
Stremai
Tumor (GIST)
............................. 740
8.9.3
Primitive Neuroectodermal Tumors (PNET) and Ewings Sarcoma
---- 742
8.9.4
Osteosarcoma
..................................................... 746
8.10
CNS Tumors
...................................................... 751
8.11
Cancer of Unknown Primary (CUP)
................................ 756
8.12
Metastasis
......................................................... 760
8.12.1
Brain
Métastases
.................................................. 762
8.12.2
Carcinomatous Meningitis (Leptomeningeal
Métastases)
............. 764
8.12.3
Lung
Métastases
................................................... 768
8.12.4
Liver
Métastases
................................................... 770
8.12.5
Bone
Métastases
................................................... 772
8.13
Paraneoplastic Syndromes
......................................... 774
9
Hematological and Oncological Emergencies
9.1
Neutropenic Sepsis
................................................ 781
9.2
Superior
Vena Cava
Syndrome (SVCS)
.............................. 783
9.3
Spinal Cord Compression
/
Cauda Equina
Syndrome
................ 785
Contents
9.4
Malignant Cardiac
Tamponade ..................................... 787
9.5
Malignant Hypercalcemia
.......................................... 789
9.6
Tumor Lysis Syndrome
............................................ 791
9.7
Hemorrhagic Complications
/
Malignant Vascular Erosion
........... 793
9.8
Transfusion Reactions
............................................. 795
9.9
Extravasation of Cytostatic Drugs
.................................. 799
10
Standard Operating Procedures (SOP)
10.1
Thoracentesis
..................................................... 802
10.2
Pleurodesis
........................................................ 804
10.3
Abdominal
Paracentesis
........................................... 806
10.4
Bone Marrow Aspiration and Biopsy
................................ 808
10.5
Basic Hematological Diagnostics
................................... 811
10.6
Lumbar Puncture (Spinal Tap) and Intrathecal Instillation
of Cytostatic Drugs
................................................ 816
10.7
Central Venous Access (CVA), Central Venous Catheter (CVC)
...... 818
10.8
Blood Cultures
.................................................... 821
11
Standardized Treatment Protocols
................................ 823
Subject Index
.............................................................. 991
XI
The Concise Manual of
Hematology
and
Oncology is a practice-oriented compendium
of medical oncology and
hematology
for
day-to-day use when caring for patients
with hematological and neoplastic diseases.
This book is founded on the longstanding
experience of a large academic reference
center, with the aim of giving the most
reliable advice possible. We have focused
on clinically validated practice and evidence-
based recommendations, which have
proven to be useful in our hands, with
specia]
emphasis on standardizing diagnostic
pathways, treatment approaches, and
chemotherapy protocols.
Berger
Engeihardt
Henß
Merteísmann
Editors
Concise Manual
of
Hematology
and Oncology
|
| adam_txt |
Contents
1
Principles of Medical Oncology
1.1
Epidemiology
. 1
1.2
Carcinogenesis, Molecular Tumor Biology
. 3
1.3
Hematopoiesis and Development of Hematological
Neoplasia
. 7
1.4
Prevention and Screening
. 10
1.5
Classification of Diseases and ICD System
. 14
1.6
Tumor Classification and TNM System
. 17
1.7
Indications for Tumor Therapy
. 19
1.8
Performance Status of Tumor Patients ("Performance Status Scales")
. 21
1.9
Response Evaluation in Solid Tumors
. 22
1.10
Common
Toxicity
Criteria (NCI)
. 25
1.11
Assessing the Quality of Life of Tumor Patients
. 30
1.12
Evidence-based Medicine (EBM), Guidelines and Quality
Management
. 32
1.13
Electronic Media
. 35
2
Special Diagnostics
2.1
Cytogenetics and Fluorescence In Situ Hybridization (FISH)
. 39
2.2
Molecular Diagnosis
. 42
2.3
Gene Expression Analysis using Microarrays
. 45
2.4
Tumor Markers
. 47
2.5
CD Antigens and Immunocytological Diagnosis
. 51
2.6
HLA
System and MHC
. 62
3
Pharmacology and Pharmacotherapy
3.1
Basic Principles of Chemotherapy
. 65
3.2
Cytostatic Drugs
. 69
3.2.1
Characteristics of Clinically Used Cytostatic Drugs
. 71
3.2.2
Check List Cytostatic Treatment
. 131
3.2.3
Drug Dosage Calculation Based on Body Surface Area (BSA)
. 132
3.2.4
Dose Adjustment of Cytostatic Drugs
. 134
3.2.5
Chemotherapy During Pregnancy and Lactation
. 141
3.2.6
Selected Cytostatic Drug Incompatibilities
. 143
3.2.7
Preparation and Stability of Cytostatics
. 146
3.3
Hormone Therapy
. 153
3.3.1
Characterization of Hormone Treatments in Oncology
. 156
3.4
Cytokines
. 170
3.5
Monoclonal Antibodies
. 178
3.6
Specific Protein Kinase Inhibitors ("Targeted Therapies")
. 188
3.7
Drug Development and Clinical Studies
. 198
3.8
Pharmacogenetics and Pharmacogenomics
. 201
4
Supportive Treatment
4.1
Antiemetic Prophylaxis and Therapy
. 204
4.2
Antibiotic Treatment and Neutropenic Fever
. 211
Contents
4.3
Growth Factors
. 218
4.4
Nutrition in Cancer Patients
. 225
4.4.1
Malnutrition in Cancer Patients
. 225
4.4.2
Parenteral Nutrition
. 232
4.5
Pain Control
. 235
4.6
Fatigue
. 241
4.7
Bisphosphonates
. 243
4.8
Malignant Effusions
. 249
4.8.1
Malignant
Pleural
Effusion
. 250
4.8.2
Malignant Pericardial Effusion
. 254
4.8.3
Malignant
Ascites
. 257
4.9
Transfusion Therapy
. 261
4.9.1
Cellular Blood Products
. 261
4.9.2
Non-cellular Blood Products
. 267
4.10
Human Sperm Cryopreservation
. 271
4.11
Cryopreservation of Human Pronuclear Oocytes
. 274
4.12
Sexual Dysfunction
. 276
4.13
Physiotherapy and Sports Medicine
. 278
4.14
Principles of Oncology Nursing Care
. 281
4.15
Psycho-oncological Care
. 286
4.16
Rehabilitation
. 289
5
Particular Treatment Procedures
5.1
Hematopoetic Stem Cell Technology (Harvesting, Culture, Purging)
. 293
5.2
Autologous Hematopoetic Stem Cell Transplantation
. 296
5.3
Allogeneic Hematopoetic Stem Cell Transplantation
. 302
5.4
Granulocyte Transfusion
. 309
5.5
Immunotherapy
. 311
5.6
Gene Therapy
. 315
5.7
Inhibition of Angiogenesis
. 319
5.8
Developmental Therapeutics
. 322
6
Hematology
and Hemostasis
6.1
Aplastic Anemia
. 327
6.2
Neutropenia and Agranulocytosis
. 332
6.3
Thrombocytopenia
. 336
6.3.1
Immune (Idiopathic) Thrombocytopenic
Purpura
(ITP, Werlhof
s
Disease)
. 339
6.3.2
Heparin-induced Thrombocytopenia (HIT)
. 343
6.3.3
Thrombotic Microangiopathies (TTP-HUS)
. 345
6.4
Anemia
. 348
6.4.1
Hypochromic Anemia
. 351
6.4.2
Megaloblastic Anemia
. 355
6.4.3
Hemolytic Anemia
. 359
6.4.4
Normochromic Anemia
. 369
6.5
Coagulation Disorders
. 371
6.5.1
Acquired Coagulation Disorders
. 376
6.5.2
Factor
VIII
Deficiency (Hemophilia A)
. 381
VIII
Contents
6.5.3
Factor
IX Deficiency (Hemophilia
В) .
384
6.5.4
Von Willebranďs
Disease (VWD)
. 386
6.5.5
Disseminated
Intravascular
Coagulation (DIC)
. 389
6.6
Thromboembolism and Thrombophilia
. 393
7
Hematological
Neoplasia
7.1
Acute
Leukémiás
. 400
7.1.1
Acute Lymphoblastic Leukemia (ALL)
. 400
7.1.2
Acute Myeloid Leukemia (AML)
. 415
7.2
Myelodysplastic Syndrome (MDS)
. 423
7.3
Myeloproliferative Disorders (MPD)
. 429
7.3.1
Chronic Myeloid Leukemia (CML)
. 431
7.3.2
Polycythemia
Vera
. 439
7.3.3
Essential Thrombocythemia
. 443
7.3.4
Chronic Idiopathic Myelofibrosis (CIMF)
. 447
7.4
Hodgkins Disease (Hodgkins Lymphoma)
. 450
7.5 Non-Hodgkins Lymphomas (NHL) . 458
7.5.1
High-grade Non-Hodgkins Lymphoma
. 463
7.5.2
Chronic Lymphocytic Leukemia (CLL)
. 470
7.5.3
Prolymphocytic Leukemia
(PLL)
. 477
7.5.4
Hairy Cell Leukemia (HCL)
. 480
7.5.5
Follicular Lymphoma (FL)
. 483
7.5.6
Mantle Cell Lymphoma (MCL)
. 488
7.5.7
Primary Cutaneous
Т
-cell
Lymphoma (CTCL)
. 492
7.5.8
Primary Lymphoma of the Central Nervous System (CNS)
. 498
7.5.9
Marginal Zone Lymphoma (MZL)
. 502
7.5.10
Multiple Myeloma
. 506
7.5.11
Immunocytoma
(Waldenström's Macroglobulinemia)
. 515
7.6 Langerhans
Cell Histiocytosis (LCH)
. 518
7.7
Mastocytosis
. 522
8
Medical Oncology
8.1
Head and Neck Tumors
. 528
8.2
Tumors of the Respiratory System
. 535
8.2.1
Lung Cancer
. 535
8.2.2
Mesotheliomas
. 546
8.2.3
Mediastinal Tumors
. 550
8.3
Gastrointestinal Tumors
. 555
8.3.1
Esophageal Carcinoma
. 555
8.3.2
Gastric Cancer
. 560
8.3.3
Cancer of the Small Intestine
. 566
8.3.4
Colorectal Cancer
. 570
8.3.5
Anal Carcinoma
. 577
8.3.6
Pancreatic Carcinoma
. 581
8.3.7
Hepatocellular Carcinoma (HCC)
. 587
8.3.8
Tumors of the Gallbladder and Bile Duct
. 593
8.4
Tumors of the Female Reproductive System
. 597
8.4.1
Breast Cancer
. 597
IX
Contents
8.4.2
Malignant Ovarian Tumors
. 611
8.4.3
Malignant Germ Cell Tumors in Women
. 619
8.4.4
Granulosa
Cell Tumors of the Ovary
. 623
8.4.5
Sertoli-Leydig Cell Tumors
. 626
8.4.6
Malignant Trophoblastic Tumors
. 628
8.4.7
Cervical Cancer
. 633
8.4.8
Endometrial Carcinoma
. 640
8.4.9
Uterine Sarcoma
. 646
8.4.10
Vaginal Cancer
. 649
8.4.11
Vulvar
Cancer
. 652
8.5
Tumors of the Male Reproductive System
. 656
8.5.1
Testicular Tumors
. 656
8.5.2
Extragonadal Germ Cell Tumors
. 665
8.5.3
Prostate Cancer
. 669
8.5.4
Penile Cancer
. 678
8.6
Tumors of the Urinary Tract
. 682
8.6.1
Renal Cell Carcinoma
. 682
8.6.2
Tumors of the Renal Pelvis, Ureter, and Bladder
. 688
8.7
Tumors of the Endocrine System
. 696
8.7.1
Thyroid Cancer
. 696
8.7.2
Neuroendocrine
Tumors (NET)
. 702
8.7.3
Malignant Pheochromocytoma and MEN
. 709
8.7.4
Tumors of the Adrenal Cortex
. 713
8.7.5
Pituitary Gland Tumors
. 716
8.8
Malignant Tumors of the Skin
. 719
8.8.1
Melanoma
. 719
8.8.2
Basal Cell Carcinoma
. 727
8.8.3
Squamous Cell Carcinoma
. 729
8.8.4 Merkel
Cell Carcinoma
. 732
8.9
Sarcomas
. 735
8.9.1
Soft Tissue Sarcoma
. 735
8.9.2
Gastrointestinal
Stremai
Tumor (GIST)
. 740
8.9.3
Primitive Neuroectodermal Tumors (PNET) and Ewings Sarcoma
---- 742
8.9.4
Osteosarcoma
. 746
8.10
CNS Tumors
. 751
8.11
Cancer of Unknown Primary (CUP)
. 756
8.12
Metastasis
. 760
8.12.1
Brain
Métastases
. 762
8.12.2
Carcinomatous Meningitis (Leptomeningeal
Métastases)
. 764
8.12.3
Lung
Métastases
. 768
8.12.4
Liver
Métastases
. 770
8.12.5
Bone
Métastases
. 772
8.13
Paraneoplastic Syndromes
. 774
9
Hematological and Oncological Emergencies
9.1
Neutropenic Sepsis
. 781
9.2
Superior
Vena Cava
Syndrome (SVCS)
. 783
9.3
Spinal Cord Compression
/
Cauda Equina
Syndrome
. 785
Contents
9.4
Malignant Cardiac
Tamponade . 787
9.5
Malignant Hypercalcemia
. 789
9.6
Tumor Lysis Syndrome
. 791
9.7
Hemorrhagic Complications
/
Malignant Vascular Erosion
. 793
9.8
Transfusion Reactions
. 795
9.9
Extravasation of Cytostatic Drugs
. 799
10
Standard Operating Procedures (SOP)
10.1
Thoracentesis
. 802
10.2
Pleurodesis
. 804
10.3
Abdominal
Paracentesis
. 806
10.4
Bone Marrow Aspiration and Biopsy
. 808
10.5
Basic Hematological Diagnostics
. 811
10.6
Lumbar Puncture (Spinal Tap) and Intrathecal Instillation
of Cytostatic Drugs
. 816
10.7
Central Venous Access (CVA), Central Venous Catheter (CVC)
. 818
10.8
Blood Cultures
. 821
11
Standardized Treatment Protocols
. 823
Subject Index
. 991
XI
The Concise Manual of
Hematology
and
Oncology is a practice-oriented compendium
of medical oncology and
hematology
for
day-to-day use when caring for patients
with hematological and neoplastic diseases.
This book is founded on the longstanding
experience of a large academic reference
center, with the aim of giving the most
reliable advice possible. We have focused
on clinically validated practice and evidence-
based recommendations, which have
proven to be useful in our hands, with
specia]
emphasis on standardizing diagnostic
pathways, treatment approaches, and
chemotherapy protocols.
Berger
Engeihardt
Henß
Merteísmann
Editors
Concise Manual
of
Hematology
and Oncology |
| any_adam_object | 1 |
| any_adam_object_boolean | 1 |
| author_GND | (DE-588)111674808 |
| building | Verbundindex |
| bvnumber | BV023335129 |
| classification_rvk | XH 1508 YC 2308 |
| ctrlnum | (OCoLC)271648600 (DE-599)DNB984966005 |
| dewey-full | 616.15 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.15 |
| dewey-search | 616.15 |
| dewey-sort | 3616.15 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| discipline_str_mv | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02104nam a2200481 c 4500</leader><controlfield tag="001">BV023335129</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20101126 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">080609s2008 gw ad|| |||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">07,N32,0653</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">984966005</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783540732761</subfield><subfield code="c">Gb. : ca. EUR 106.95 (freier Pr.), ca. sfr 174.00 (freier Pr.)</subfield><subfield code="9">978-3-540-73276-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3540732764</subfield><subfield code="c">Gb. : ca. EUR 106.95 (freier Pr.), ca. sfr 174.00 (freier Pr.)</subfield><subfield code="9">3-540-73276-4</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783540732761</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">11531630</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)271648600</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB984966005</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BE</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.15</subfield><subfield code="2">22/ger</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 1508</subfield><subfield code="0">(DE-625)152870:12914</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">YC 2308</subfield><subfield code="0">(DE-625)153200:12914</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Concise manual of hematology and oncology</subfield><subfield code="b">with 474 tables</subfield><subfield code="c">ed. D. P. Berger ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin [u.a.]</subfield><subfield code="b">Springer</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXI, 1002 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Hämatologie</subfield><subfield code="0">(DE-588)4022796-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Hämatologie</subfield><subfield code="0">(DE-588)4022796-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berger, Dietmar Paul</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)111674808</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016519008&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016519008&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Klappentext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-016519008</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV023335129 |
| illustrated | Illustrated |
| index_date | 2024-07-02T20:59:18Z |
| indexdate | 2024-07-09T21:16:13Z |
| institution | BVB |
| isbn | 9783540732761 3540732764 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-016519008 |
| oclc_num | 271648600 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-19 DE-BY-UBM |
| owner_facet | DE-355 DE-BY-UBR DE-19 DE-BY-UBM |
| physical | XXI, 1002 S. Ill., graph. Darst. |
| publishDate | 2008 |
| publishDateSearch | 2008 |
| publishDateSort | 2008 |
| publisher | Springer |
| record_format | marc |
| spelling | Concise manual of hematology and oncology with 474 tables ed. D. P. Berger ... Berlin [u.a.] Springer 2008 XXI, 1002 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Hämatologie (DE-588)4022796-0 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Hämatologie (DE-588)4022796-0 s DE-604 Krebs Medizin (DE-588)4073781-0 s Berger, Dietmar Paul Sonstige (DE-588)111674808 oth Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016519008&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016519008&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA Klappentext |
| spellingShingle | Concise manual of hematology and oncology with 474 tables Krebs Medizin (DE-588)4073781-0 gnd Hämatologie (DE-588)4022796-0 gnd |
| subject_GND | (DE-588)4073781-0 (DE-588)4022796-0 (DE-588)4143413-4 |
| title | Concise manual of hematology and oncology with 474 tables |
| title_auth | Concise manual of hematology and oncology with 474 tables |
| title_exact_search | Concise manual of hematology and oncology with 474 tables |
| title_exact_search_txtP | Concise manual of hematology and oncology with 474 tables |
| title_full | Concise manual of hematology and oncology with 474 tables ed. D. P. Berger ... |
| title_fullStr | Concise manual of hematology and oncology with 474 tables ed. D. P. Berger ... |
| title_full_unstemmed | Concise manual of hematology and oncology with 474 tables ed. D. P. Berger ... |
| title_short | Concise manual of hematology and oncology |
| title_sort | concise manual of hematology and oncology with 474 tables |
| title_sub | with 474 tables |
| topic | Krebs Medizin (DE-588)4073781-0 gnd Hämatologie (DE-588)4022796-0 gnd |
| topic_facet | Krebs Medizin Hämatologie Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016519008&sequence=000003&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=016519008&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT bergerdietmarpaul concisemanualofhematologyandoncologywith474tables |